SORRY FOR THE DELAY BUT, WE'RE BACK AT IT!
On this episode, we finish our How to Become an Air Force Nurse series with Part 3, Nurse Enlisted Commissioning Program (NECP). We sit down with MSgt Mike McCabe and TSgt Shenique Deninger and discuss their backgrounds, what is NECP (past and present), getting through the process, and some inside tips from the board itself.
If we did not cover something you would like to hear more on, please let us know.
Resources:
Air Force Instruction (AFI) 36-2032, Military Recruiting and Accessions
AY21 NECP Application Guidance
Facebook page: USAF NECP
Have a question or comment?
Email us at bottomlinenursing@gmail.com
Follow us on Facebook
Follow us on Instagram @bottomlinenursing
Visit our Website
Music: The Smell of Success by Shane Ivers - https://www.silvermansound.com
Disclaimer: The views expressed are those of the hosts and do not reflect the official policy or position of any specific organization or entity. The mention of companies by name is solely for the purpose of discussion and should not be implied as endorsement.
SORRY FOR THE DELAY BUT, WE'RE BACK AT IT!
On this episode, we finish our How to Become an Air Force Nurse series with Part 3, Nurse Enlisted Commissioning Program (NECP). We sit down with MSgt Mike McCabe and TSgt Shenique Deninger and discuss their backgrounds, what is NECP (past and present), getting through the process, and some inside tips from the board itself.
If we did not cover something you would like to hear more on, please let us know.
Resources:
Air Force Instruction (AFI) 36-2032, Military Recruiting and Accessions
AY21 NECP Application Guidance
Facebook page: USAF NECP
Have a question or comment?
Email us at bottomlinenursing@gmail.com
Follow us on Facebook
Follow us on Instagram @bottomlinenursing
Visit our Website
Music: The Smell of Success by Shane Ivers - https://www.silvermansound.com
Disclaimer: The views expressed are those of the hosts and do not reflect the official policy or position of any specific organization or entity. The mention of companies by name is solely for the purpose of discussion and should not be implied as endorsement.